Mycoplasma hominis and Candidatus Mycoplasma girerdii in Trichomonas vaginalis: Peaceful Cohabitants or Contentious Roommates?

Trichomonas vaginalis is a pathogenic protozoan diffused worldwide capable of infecting the urogenital tract in humans, causing trichomoniasis. One of its most intriguing aspects is the ability to establish a close relationship with endosymbiotic microorganisms: the unique association of T. vaginalis with the bacterium Mycoplasma hominis represents, to date, the only example of an endosymbiosis involving two true human pathogens. Since its discovery, several aspects of the symbiosis between T. vaginalis and M. hominis have been characterized, demonstrating that the presence of the intracellular guest strongly influences the pathogenic characteristics of the protozoon, making it more aggressive towards host cells and capable of stimulating a stronger proinflammatory response. The recent description of a further symbiont of the protozoon, the newly discovered non-cultivable mycoplasma Candidatus Mycoplasma girerdii, makes the picture even more complex. This review provides an overview of the main aspects of this complex microbial consortium, with particular emphasis on its effect on protozoan pathobiology and on the interplays among the symbionts.

[1]  A. Rostami,et al.  Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis , 2023, PloS one.

[2]  Po-Jung Huang,et al.  Metabolomics analysis reveals changes related to pseudocyst formation induced by iron depletion in Trichomonas vaginalis , 2023, Parasites & Vectors.

[3]  Z. Fasoulakis,et al.  Maternal Infection and Preterm Birth: From Molecular Basis to Clinical Implications , 2023, Children.

[4]  J. Walochnik,et al.  Detection of Putative Virulence Genes alr, goiB, and goiC in Mycoplasma hominis Isolates from Austrian Patients , 2023, International journal of molecular sciences.

[5]  Zhenchao Zhang,et al.  Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis. , 2023, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[6]  J. Walochnik,et al.  The Prevalence of Genital Mycoplasmas and Coinfection with Trichomonas vaginalis in Female Patients in Vienna, Austria , 2023, Microorganisms.

[7]  T. Tasca,et al.  Infinity war: Trichomonas vaginalis and interactions with host immune response , 2023, Microbial cell.

[8]  A. Simoes-Barbosa,et al.  A Microbial Piñata: Bacterial Endosymbionts of Trichomonas vaginalis Come in Different Flavors , 2022, mBio.

[9]  N. Low,et al.  Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum: a systematic review and meta-analysis , 2022, BMJ Open.

[10]  D. Dessì,et al.  Effect of the Symbiosis with Mycoplasma hominis and Candidatus Mycoplasma Girerdii on Trichomonas vaginalis Metronidazole Susceptibility , 2022, Antibiotics.

[11]  Jennifer M. Fettweis,et al.  Two Different Species of Mycoplasma Endosymbionts Can Influence Trichomonas vaginalis Pathophysiology , 2022, mBio.

[12]  K. Ghanem,et al.  Diagnosis and Treatment of Sexually Transmitted Infections: A Review. , 2022, JAMA.

[13]  R. Schonman,et al.  Characteristics of Pelvic Inflammatory Disease caused by Sexually transmitted disease - An epidemiologic Study. , 2021, Journal of gynecology obstetrics and human reproduction.

[14]  Zhixin Wang,et al.  High Co-Infection Rate of Trichomonas vaginalis and Candidatus Mycoplasma Girerdii in Gansu Province, China , 2021, Healthcare.

[15]  Ravesh Singh,et al.  ‘Mycoplasma hominis does not share common risk factors with other genital pathogens’: Findings from a South African pregnant cohort , 2021, Southern African journal of infectious diseases.

[16]  Z. Zhou,et al.  Atomic Structure of the Trichomonas vaginalis Double-Stranded RNA Virus 2 , 2021, mBio.

[17]  M. L. Sallas,et al.  Microbiome and Cervical Cancer , 2020, Pathobiology.

[18]  P. Tinarwo,et al.  Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance , 2020, Parasitology Research.

[19]  P. Kissinger,et al.  A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis , 2020, Parasitology.

[20]  P. Rappelli,et al.  Impact of Symbiosis Between Trichomonas vaginalis and Mycoplasma hominis on Vaginal Dysbiosis: A Mini Review , 2020, Frontiers in Cellular and Infection Microbiology.

[21]  N. Low,et al.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 , 2019, Bulletin of the World Health Organization.

[22]  G. Donders,et al.  Prevalence of Ureaplasma spp. and Mycoplasma hominis in healthy women and patients with flora alterations. , 2019, Diagnostic microbiology and infectious disease.

[23]  E. Platz,et al.  Association between Trichomonas vaginalis and prostate cancer mortality , 2018, International journal of cancer.

[24]  D. Dessì,et al.  Trichomonas vaginalis Transports Virulent Mycoplasma hominis and Transmits the Infection to Human Cells after Metronidazole Treatment: A Potential Role in Bacterial Invasion of Fetal Membranes and Amniotic Fluid , 2018, Journal of pregnancy.

[25]  Radhey S. Gupta,et al.  Phylogenetic framework for the phylum Tenericutes based on genome sequence data: proposal for the creation of a new order Mycoplasmoidales ord. nov., containing two new families Mycoplasmoidaceae fam. nov. and Metamycoplasmataceae fam. nov. harbouring Eperythrozoon, Ureaplasma and five novel genera , 2018, Antonie van Leeuwenhoek.

[26]  J. Walochnik,et al.  Mycoplasma hominis impacts gene expression in Trichomonas vaginalis , 2018, Parasitology Research.

[27]  D. Leitsch A review on metronidazole: an old warhorse in antimicrobial chemotherapy , 2017, Parasitology.

[28]  L. Petricevic,et al.  Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen , 2017, Journal of perinatal medicine.

[29]  Christine L. Sun,et al.  Candidatus Mycoplasma girerdii replicates, diversifies, and co-occurs with Trichomonas vaginalis in the oral cavity of a premature infant , 2017, Scientific Reports.

[30]  P. Rappelli,et al.  Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma. , 2017, Research in microbiology.

[31]  Patricia J. Johnson,et al.  Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis , 2016, PLoS neglected tropical diseases.

[32]  D. Dessì,et al.  Symbiotic Association with Mycoplasma hominis Can Influence Growth Rate, ATP Production, Cytolysis and Inflammatory Response of Trichomonas vaginalis , 2016, Front. Microbiol..

[33]  R. Fichorova,et al.  Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and -3 to Modulate Epithelial Immunity , 2015, The Journal of Biological Chemistry.

[34]  Odelta dos Santos,et al.  High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[35]  Jennifer M. Fettweis,et al.  Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. , 2015, American journal of obstetrics and gynecology.

[36]  G. Hobbs,et al.  Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis , 2014, Critical reviews in microbiology.

[37]  Jennifer M. Fettweis,et al.  An Emerging Mycoplasma Associated with Trichomoniasis, Vaginal Infection and Disease , 2014, PloS one.

[38]  J. Kaldor,et al.  Trichomonas vaginalis as a Cause of Perinatal Morbidity: A Systematic Review and Meta-Analysis , 2014, Sexually transmitted diseases.

[39]  Pier Luigi Fiori,et al.  Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses , 2014, Proceedings of the National Academy of Sciences.

[40]  Patricia J. Johnson,et al.  Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance , 2014, Molecular microbiology.

[41]  D. Relman,et al.  Microbiome Assembly across Multiple Body Sites in Low-Birthweight Infants , 2013, mBio.

[42]  R. Lillis,et al.  Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. , 2013, The Journal of infectious diseases.

[43]  Gilbert GREUB,et al.  Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes , 2013, Current opinion in infectious diseases.

[44]  D. Dessì,et al.  Association of Trichomonas vaginalis with its symbiont Mycoplasma hominis synergistically upregulates the in vitro proinflammatory response of human monocytes , 2013, Sexually Transmitted Infections.

[45]  Kristin N. Parent,et al.  Structure of a Protozoan Virus from the Human Genitourinary Parasite Trichomonas vaginalis , 2013, mBio.

[46]  W. Secor,et al.  Trichomonas vaginalis Contact-Dependent Cytolysis of Epithelial Cells , 2013, Infection and Immunity.

[47]  Zaid Abdo,et al.  Association Between Trichomonas vaginalis and Vaginal Bacterial Community Composition Among Reproductive-Age Women , 2012, Sexually transmitted diseases.

[48]  J. Fraga,et al.  Mycoplasma hominis in Cuban Trichomonas vaginalis isolates: association with parasite genetic polymorphism. , 2012, Experimental parasitology.

[49]  Patricia J. Johnson,et al.  Trichomonas vaginalis: current understanding of host-parasite interactions. , 2011, Essays in biochemistry.

[50]  Russell P. Goodman,et al.  Clinical Isolates of Trichomonas vaginalis Concurrently Infected by Strains of Up to Four Trichomonasvirus Species (Family Totiviridae) , 2011, Journal of Virology.

[51]  D. Dessì,et al.  Arginine metabolism in Trichomonas vaginalis infected with Mycoplasma hominis , 2010, Microbiology.

[52]  S. Sutcliffe Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. , 2010, Future oncology.

[53]  W. Secor,et al.  Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States , 2010, Parasitology Research.

[54]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[55]  D. Chakravortty,et al.  Modulation of the Arginase Pathway in the Context of Microbial Pathogenesis: A Metabolic Enzyme Moonlighting as an Immune Modulator , 2010, PLoS pathogens.

[56]  T. Sicheritz-Pontén,et al.  Trichomonas vaginalis vast BspA-like gene family: evidence for functional diversity from structural organisation and transcriptomics , 2010, BMC Genomics.

[57]  R. Fichorova Impact of T. vaginalis infection on innate immune responses and reproductive outcome. , 2009, Journal of reproductive immunology.

[58]  Alain Blanchard,et al.  Life on Arginine for Mycoplasma hominis: Clues from Its Minimal Genome and Comparison with Other Human Urogenital Mycoplasmas , 2009, PLoS genetics.

[59]  L. Baum,et al.  Galectin‐1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis , 2008, Cellular microbiology.

[60]  R. Borojevic,et al.  Trichomonas vaginalis harboring Mycoplasma hominis increases cytopathogenicity in vitro , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[61]  R. Vancini,et al.  Entry and intracellular location of Mycoplasma hominis in Trichomonas vaginalis , 2007, Archives of Microbiology.

[62]  J. Baeten,et al.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. , 2007, The Journal of infectious diseases.

[63]  Richard D. Hayes,et al.  Draft Genome Sequence of the Sexually Transmitted Pathogen Trichomonas vaginalis , 2007, Science.

[64]  Z. Lun,et al.  Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro , 2006, Parasitology Research.

[65]  D. Dessì,et al.  Long-Term Survival and Intracellular Replication of Mycoplasma hominis in Trichomonas vaginalis Cells: Potential Role of the Protozoon in Transmitting Bacterial Infection , 2005, Infection and Immunity.

[66]  N. Sewankambo,et al.  Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. , 2003, American journal of obstetrics and gynecology.

[67]  Brett A. Collins,et al.  Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. , 2001, The New England journal of medicine.

[68]  C. Beard,et al.  Molecular Epidemiology of Metronidazole Resistance in a Population of Trichomonas vaginalis Clinical Isolates , 2000, Journal of Clinical Microbiology.

[69]  P. Fiori,et al.  Mycoplasma hominis parasitism of Trichomonas vaginalis , 1998, The Lancet.

[70]  G. Garber,et al.  Clinical and Microbiological Aspects ofTrichomonas vaginalis , 1998, Clinical Microbiology Reviews.

[71]  M. Krohn,et al.  Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery , 1997, Sexually transmitted diseases.

[72]  C. Wang,et al.  A linear double-stranded RNA in Trichomonas vaginalis. , 1985, The Journal of biological chemistry.

[73]  M. Nielsen The ultrastructure of Trichomonas vaginalis donné before and after transfer from vaginal secretion to Diamonds medium. , 1975, Acta pathologica et microbiologica Scandinavica. Supplement.

[74]  A. Simoes-Barbosa,et al.  Vaginal dysbiotic bacteria act as pathobionts of the protozoal pathogen Trichomonas vaginalis. , 2019, Microbial pathogenesis.

[75]  J. Fraga,et al.  Genetic characterization of three Cuban Trichomonas vaginalis virus. Phylogeny of Totiviridae family. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[76]  J. Mottram,et al.  Trichomonas vaginalis pathobiology new insights from the genome sequence. , 2011, Advances in parasitology.